Back to UBS Group AG UBS Group AG

TMCITMCI
Showing 8 of 20 quarters

Position history for UBS Group AGUBS Group AG's holdings in TREACE MED CONCEPTS INC

UBS Group AG holds 542,905 shares of TMCI (TREACE MED CONCEPTS INC), worth $727,493 as of 2026-Q1. The position was increased (+84.7% shares). TMCI represents 0.0% of UBS Group AG's portfolio.

Current Value

$727,493

Current Shares

542,905

Total Value Change

+$461,367

Total Shares Change

+502,886

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
542,905
+84.7%
$727,4930.0%$1.57
38
2025-Q4
Increased
293,929
+3.7%
$720,1260.0%$2.48
26
2025-Q3
Decreased
283,349
-24.9%
$1.9M0.0%$6.72
0
2025-Q2
Increased
377,447
+4.5%
$2.2M0.0%$5.75
27
2025-Q1
Decreased
361,319
-62.7%
$3M0.0%$8.45
0
2024-Q4
Increased
968,434
+1174.6%
$7.2M0.0%$6.88
44
2024-Q3
Increased
75,978
+89.8%
$440,6730.0%$5.77
38
2024-Q2
Decreased
40,019
-52.8%
$266,1260.0%$6.65
0

Other major holders of TMCI: CIBC Bancorp USA Inc., CIBC Private Wealth Group LLC, ALLIANCEBERNSTEIN L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used